From Matt Schissler --ANS - BioCells is delayed just a few days. Simply put, there are both English and Spanish speaking attorneys and the documents have to be done in both languages. This is the reason for the delay. Nothing else. We suspect only a couple of more days. As for the placenta revenue, it depends upon the demand for it. Because the demand is research driven, we are unsure. CBAI has put ourselves in position to be a great supplier if the demand does increase. The demand comes from R&D, not families, so its tough to tell. That said, I do believe it will increase significantly over time.See More
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.